Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Breast Cancer Research

Issue 2/2000

Content (12 Articles)

Commentary

Breast cancer research: where we are and where we should go

Edison T Liu

Commentary

Founder populations and their uses for breast cancer genetics

Susan L Neuhausen

Commentary

Caretaker Brca1: keeping the genome in the straight and narrow

Veronica Yu

Review

Signal transducers and activators of transcription as regulators of growth, apoptosis and breast development

Jacqueline Bromberg

Review

Transforming growth factor-β and breast cancer: Introduction

Joyce Slingerland

Review

Transforming growth factor-β and breast cancer: Mammary gland development

Mary Helen Barcellos-Hoff, Kenneth BR Ewan

Review

Transforming growth factor-β and breast cancer: Lessons learned from genetically altered mouse models

Lalage M Wakefield, Yu-an Yang, Oksana Dukhanina

Review

Transforming growth factor-β and breast cancer: Transforming growth factor-β/SMAD signaling defects and cancer

Marcus Kretzschmar

Review

Transforming growth factor-β and breast cancer: Cell cycle arrest by transforming growth factor-β and its disruption in cancer

Jeffrey Donovan, Joyce Slingerland

Review

Transforming growth factor-beta and breast cancer: Tumor promoting effects of transforming growth factor-β

Nancy Dumont, Carlos L Arteaga

Open Access Research article

Increased cell survival by inhibition of BRCA1 using an antisense approach in an estrogen responsive ovarian carcinoma cell line

Lois A Annab, Rebecca Hawkins, Greg Solomon, J Carl Barrett, Cynthia A Afshari

Meeting report

22nd Annual San Antonio Breast Cancer Symposium, 8-11 December 1999, San Antonio, Texas, USA

Robert B Clarke, Elizabeth Anderson

Mar 00
Issue: Special Issue 1/2000
Second International Symposium on the Molecular Biology of Breast Cancer
Jun 00
Issue: 3/2000

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits